Filing Details
- Accession Number:
- 0001437749-16-034194
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-21 17:51:58
- Reporting Period:
- 2016-06-17
- Filing Date:
- 2016-06-21
- Accepted Time:
- 2016-06-21 17:51:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879682 | Viveve Medical Inc. | VIVE | Electromedical & Electrotherapeutic Apparatus (3845) | 043153858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1493500 | Scott Durbin | 150 Commercial Street Sunnyvale CA 94086 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-17 | 1,500 | $5.00 | 6,568 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reporting person purchased these shares in connection with the closing of a public offering of the Issuer's common stock (the "Offering") at the Offering price of $5.00 per share. The shares are subject to a lock-up provision for a period of 90 days following June 14, 2016, as required under a lock-up agreement with the underwriters of the Offering.
- On April 15, 2016, the Issuer effected a 1-for-8 reverse stock split of its common stock (the "Split"), which began trading on a post-Split basis on April 18, 2016. The amount reported in Column 5 represents securities beneficially owned on a post-Split basis.